Identification and Validation of a PD-L1 Binding Peptide for Determination of PDL1 Expression in Tumors

Scientific Reports - United Kingdom
doi 10.1038/s41598-017-10946-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

PD-L1 Expression in Inflammatory Myofibroblastic Tumors

Modern Pathology
Forensic MedicinePathology
2018English

P3.12-05 the Pattern of PD-L1 Expression in Thoracic Neuroendocrine Tumors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Tumor-Infiltrating T Cells and PD-L1 Expression in Childhood Malignant Extracranial Germ-Cell Tumors

OncoImmunology
OncologyAllergyImmunology
2018English

OR12: Expression and Localization of PD‐1 and PD‐L1 in Mouse Testes

American Journal of Reproductive Immunology
GynecologyReproductive MedicineImmunologyObstetricsAllergy
2019English

Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors

Frontiers in Oncology
Cancer ResearchOncology
2019English

The Expression of PD-L1 in Salivary Gland Carcinomas

Scientific Reports
Multidisciplinary
2019English

Comprehensive Analysis of PD-L1 Expression in Glioblastoma Multiforme

Oncotarget
Oncology
2017English

Programmed Death Ligand 1 (PD-L1) Expression in Epithelial Ovarian Cancer: A Comparison of Type I and Type II Tumors

Asian Pacific Journal of Cancer Prevention
2019English

45. A Retrospective Assessment of PD-L1 Expression Rates in NSCLC

Pathology
Forensic MedicinePathology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy